LEO PHARMA
LEO Pharma is a medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.
LEO PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1908-01-01
Address:
Ballerup, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.leo-pharma.com
Total Employee:
5001+
Status:
Active
Contact:
45 44 94 58 88
Total Funding:
450 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Apache Wordpress Plugins
Similar Organizations
The Association of the British Pharmaceutical Industry
ABPI is a research-based biopharmaceutical companies.
BioInvent
BioInvent is a research-based pharmaceutical company.
Celon Pharma
Celon Pharma is an integrated pharmaceutical company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Clavis Pharma
Clavis Pharma is a healthcare and clinical-stage pharmaceutical company.
EpyGenix Therapeutics
Epygenix Therapeutics is a precision medicine-based biopharmaceutical company
Eurofarma
Eurofarma is a Brazilian multinational pharmaceutical company.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Martindale Pharma
Martindale Pharma is an international specialty pharma company.
Medice Arzneimittel
This company is one of the most successful family-owned pharmaceutical companies in Germany.
PharmaDM
PharmaDM is a target and drug discovery Pharma-informatics company.
Takeda Oncology
Takeda Oncology is a leading biopharmaceutical company.
Trajectum Pharma
Trajectum Pharma is an innovative biopharmaceutical company
Union Chimique Belge
UCB is a biopharma company that focuses on the research and development of medication for neurology and immunology diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Nordic Capital
Nordic Capital investment in Private Equity Round - LEO Pharma
Key Employee Changes
Official Site Inspections
http://www.leo-pharma.com Semrush global rank: 1.73 M Semrush visits lastest month: 13.79 K
- Host name: 20.50.2.20
- IP address: 20.50.2.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "LEO Pharma"
About LEO Pharma
About LEO Pharma Learn about our 115-year history and join us on our new exciting journey. Company History From humble beginnings in the basement of the Copenhagen LEO …See details»
Leo Pharma - Wikipedia
LEO Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries. Its headquarters are in Ballerup, near Copenhagen The company is 100% integrated into a private foundation owned by the LEO Foundation. LEO Pharma develops and markets products for dermatology, bone remodeling thrombosis and coagulation. In 1945, it was the first producer of penicillin outside the US and UK. See details»
Who we are - LEO Pharma
Our headquarters are in Denmark with a global team of 4,200 people serving millions of patients accross the world. LEO Pharma started manufacturing products in Ireland in 1958 and has …See details»
LEO Pharma - Crunchbase Company Profile & Funding
LEO Pharma is a leading global pharma company specializing in dermatology and critical care. For more than a century, our products have improved …See details»
Leo Pharma - Leadership Team | The Org
The Leadership Team at Leo Pharma is responsible for setting the strategic direction and vision for the company across its global operations. This team collaborates on key decisions related …See details»
LEO Pharma unveils ambitious 2030 strategy …
LEO Pharma will accelerate its R&D efforts and rapidly diversify its portfolio of innovative medicines to cover a range of dermatological indications including rare diseases. This will create new treatment options for people living with skin …See details»
Dermatology beyond the skin | LEO Pharma
Mar 6, 2025 In Q1, LEO Pharma continued its robust growth, driven by dermatology, and made significant strategic progress. This included expanding the launch of Anzupgo® to five markets...See details»
LEO Pharma introduces a new operating model and organizational ...
Jan 26, 2022 Following the new strategy, LEO Pharma’s Global R&D organization will focus the in-house drug discovery on promising small molecule technologies and further increasing …See details»
LEO Pharma | WEPs
Feb 21, 2025 LEO Pharma Christophe Bourdon (M) CEO At LEO Pharma, we are proud to commit to the Women's Empowerment Principles, recognizing the invaluable contributions of …See details»
Company History | LEO Pharma
From 2009-2019 In 2009, LEO Pharma launches a new global strategy 'Going for Gold - step by step' with the stated ambition of growing the company. The success criteria are to maintain the …See details»
Our annual reporting | LEO Pharma
LEO Pharma's Annual Report covers our financial and sustainability reporting for the financial year from January 1 to December 31.See details»
About LEO Pharma
About LEO Pharma Learn about our 113-year history and join us on our new exciting journey. Company History From humble beginnings in the basement of the Copenhagen LEO …See details»
Your Career | LEO Pharma
LEO Pharma is more than just a workplace - it's a community. Here, everyone has the power to make a difference. Our organization is built on a culture of care, mutual respect, and a shared …See details»
Our leadership | LEO Pharma
The Global Leadership Team is responsible for overall business growth, strategic direction and daily operations.See details»
Dermatology beyond the skin | LEO Pharma
Medical dermatology LEO Pharma A/S has dedicated decades of research and development to advance the science of dermatology.See details»
LEO Pharma strengthens its commercial organization
LEO Pharma strengthens its commercial organization Ballerup – June 2, 2022 – As part of LEO Pharma’s transformation towards becoming a global leader in medical dermatology, the …See details»
What we stand for | LEO Pharma
Our shared vision and mission adapt to an ever-changing environment, while remaining true to our business strategy. Our values reflect the way we strive to increase the quality of life for …See details»
2025 Boehringer Ingelheim and LEO Pharma enter partnership
Jul 14, 2025 Boehringer Ingelheim and LEO Pharma will closely cooperate to ensure a smooth transition of all operations Ingelheim, Germany & Ballerup, Denmark, July 14, 2025 – …See details»
LEO bulks up with deal for Boehringer skin drug | pharmaphorum
6 days ago LEO is claiming global commercial rights to Spevigo for GPP, but will also collaborate with Boehringer on potential follow-up IL-36 mediated skin diseases, such as …See details»
Leo ponies up €90 million for Boehringer Ingelheim's Spevigo
Jul 14, 2025 Leo Pharma has struck a partnership with Boehringer Ingelheim, paying 90 million euros ($105 million) up front to develop and commercialize Spevigo.See details»